Clustering of the metabolic syndrome components in adolescence: Role of visceral fat

PLoS ONE

Volumn 8, Issue 12, 2013, Pages

  Melka, Melkaye G ^a   Abrahamowicz, Michal ^b   Leonard, Gabriel T ^c   Perron, Michel ^d,e   Richer, Louis ^e   Veillette, Suzanne ^d,e   Gaudet, Daniel ^f   Paus, Tomáš ^g   Pausova, Zdenka ^a  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c MCGILL UNIVERSITY   (Canada)

^d Groupe ICOBES Recherche et Transfert   (Canada)

^e UNIVERSITÉ DU QUÉBEC À CHICOUTIMI   (Canada)

^f UNIVERSITÉ DE MONTRÉAL   (Canada)

^g UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ABDOMINAL OBESITY; ADOLESCENT; ADULT; ARTICLE; CHILD; COMMUNITY SAMPLE; FEMALE; HUMAN; INSULIN RESISTANCE; INTRAABDOMINAL FAT; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; NUCLEAR MAGNETIC RESONANCE IMAGING; PRINCIPAL COMPONENT ANALYSIS; SEX DIFFERENCE; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE; CLUSTER ANALYSIS; PATHOLOGY;

ADOLESCENT; CHILD; CLUSTER ANALYSIS; FEMALE; HUMANS; INTRA-ABDOMINAL FAT; MALE; METABOLIC SYNDROME X; PRINCIPAL COMPONENT ANALYSIS; WAIST CIRCUMFERENCE;

EID: 84893401612     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0082368     Document Type: Article

References (58)

1. Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, et al. (2009) Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 120: 1640-1645.
2. Wilson PW, D'Agostino RB, Parise H, Sullivan L, Meigs JB (2005) Metabolic syndrome as a precursor of cardiovascular disease and type 2 diabetes mellitus. Circulation 112: 3066-3072. (Pubitemid 43113437)
3. Anand SS, Yi Q, Gerstein H, Lonn E, Jacobs R, et al. (2003) Relationship of metabolic syndrome and fibrinolytic dysfunction to cardiovascular disease. Circulation 108: 420-425. (Pubitemid 36935534)
4. Ford ES, Giles WH, Dietz WH (2002) Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. Jama 287: 356-359. (Pubitemid 34251969)
5. Meigs JB, Wilson PW, Nathan DM, D'Agostino RB, Sr., Williams K, et al. (2003) Prevalence and characteristics of the metabolic syndrome in the San Antonio Heart and Framingham Offspring Studies. Diabetes 52: 2160-2167. (Pubitemid 36919812)
6. Steinberger J, Daniels SR, Eckel RH, Hayman L, Lustig RH, et al. (2009) Progress and challenges in metabolic syndrome in children and adolescents: a scientific statement from the American Heart Association Atherosclerosis, Hypertension, and Obesity in the Young Committee of the Council on Cardiovascular Disease in the Young; Council on Cardiovascular Nursing; and Council on Nutrition, Physical Activity, and Metabolism. Circulation 119: 628-647.
7. Cook S, Weitzman M, Auinger P, Nguyen M, Dietz WH (2003) Prevalence of a metabolic syndrome phenotype in adolescents: findings from the third National Health and Nutrition Examination Survey, 1988-1994. Arch Pediatr Adolesc Med 157: 821-827. (Pubitemid 36988016)
8. Johnson WD, Kroon JJ, Greenway FL, Bouchard C, Ryan D, et al. (2009) Prevalence of risk factors for metabolic syndrome in adolescents: National Health and Nutrition Examination Survey (NHANES), 2001-2006. Arch Pediatr Adolesc Med 163: 371-377.
9. (2004) Prevalence of adolescent overweight and obesity in Canada in 1978/79 and 2004. Canadian Community Health Survey.
10. Ogden CL, Flegal KM, Carroll MD, Johnson CL (2002) Prevalence and trends in overweight among US children and adolescents, 1999-2000. Jama 288: 1728-1732.
11. Fox CS, Massaro JM, Hoffmann U, Pou KM, Maurovich-Horvat P, et al. (2007) Abdominal visceral and subcutaneous adipose tissue compartments: association with metabolic risk factors in the Framingham Heart Study. Circulation 116: 39-48. (Pubitemid 47016245)
12. Demerath EW, Reed D, Rogers N, Sun SS, Lee M, et al. (2008) Visceral adiposity and its anatomical distribution as predictors of the metabolic syndrome and cardiometabolic risk factor levels. Am J Clin Nutr 88: 1263-1271.
13. Smith JD, Borel AL, Nazare JA, Haffner SM, Balkau B, et al. (2012) Visceral adipose tissue indicates the severity of cardiometabolic risk in patients with and without type 2 diabetes: results from the INSPIRE ME IAA study. J Clin Endocrinol Metab 97: 1517-1525.
14. Wildman RP, Muntner P, Reynolds K, McGinn AP, Rajpathak S, et al. (2008) The obese without cardiometabolic risk factor clustering and the normal weight with cardiometabolic risk factor clustering: prevalence and correlates of 2 phenotypes among the US population (NHANES 1999-2004). Arch Intern Med 168: 1617-1624.
15. Vega GL, Adams-Huet B, Peshock R, Willett D, Shah B, et al. (2006) Influence of body fat content and distribution on variation in metabolic risk. J Clin Endocrinol Metab 91: 4459-4466. (Pubitemid 44833423)
16. Narkiewicz K, Phillips BG, Kato M, Hering D, Bieniaszewski L, et al. (2005) Gender-selective interaction between aging, blood pressure, and sympathetic nerve activity. Hypertension 45: 522-525. (Pubitemid 40411253)
17. Syme C, Abrahamowicz M, Leonard GT, Perron M, Pitiot A, et al. (2008) Intra-abdominal adiposity and individual components of the metabolic syndrome in adolescence: sex differences and underlying mechanisms. Arch Pediatr Adolesc Med 162: 453-461. (Pubitemid 351656561)
18. Pausova Z, Mahboubi A, Abrahamowicz M, Leonard GT, Perron M, et al. (2012) Sex differences in the contributions of visceral and total body fat to blood pressure in adolescence. Hypertension 59: 572-579.
19. McGill HC, Jr., McMahan CA (2003) Starting earlier to prevent heart disease. Jama 290: 2320-2322.
20. Pausova Z, Paus T, Abrahamowicz M, Almerigi J, Arbour N, et al. (2007) Genes, maternal smoking, and the offspring brain and body during adolescence: design of the Saguenay Youth Study. Hum Brain Mapp 28: 502-518. (Pubitemid 46849367)
21. Cornier MA, Despres JP, Davis N, Grossniklaus DA, Klein S, et al. (2011) Assessing Adiposity: A Scientific Statement From the American Heart Association. Circulation 124: 1996-2019.
22. Brambilla P, Bedogni G, Moreno LA, Goran MI, Gutin B, et al. (2006) Crossvalidation of anthropometry against magnetic resonance imaging for the assessment of visceral and subcutaneous adipose tissue in children. Int J Obes (Lond) 30: 23-30. (Pubitemid 41790773)
23. Hu HH, Nayak KS, Goran MI (2011) Assessment of abdominal adipose tissue and organ fat content by magnetic resonance imaging. Obes Rev 12: e504-515.
24. Syme C, Abrahamowicz M, Leonard GT, Perron M, Richer L, et al. (2009) Sex differences in blood pressure and its relationship to body composition and metabolism in adolescence. Arch Pediatr Adolesc Med 163: 818-825.
25. Tanaka H, Thulesius O, Yamaguchi H, Mino M, Konishi K (1994) Continuous non-invasive finger blood pressure monitoring in children. Acta Paediatr 83: 646-652. (Pubitemid 24197623)
26. Paradis G, Lambert M, O'Loughlin J, Lavallee C, Aubin J, et al. (2004) Blood pressure and adiposity in children and adolescents. Circulation 110: 1832-1838. (Pubitemid 39299226)
27. Grebla RC, Rodriguez CJ, Borrell LN, Pickering TG (2010) Prevalence and determinants of isolated systolic hypertension among young adults: the 1999-2004 US National Health And Nutrition Examination Survey. J Hypertens 28: 15-23.
28. Griffith TF, Klassen PS, Franklin SS (2005) Systolic hypertension: an overview. Am Heart J 149: 769-775. (Pubitemid 40718870)
29. Fernandez JR, Redden DT, Pietrobelli A, Allison DB (2004) Waist circumference percentiles in nationally representative samples of African-American, European-American, and Mexican-American children and adolescents. J Pediatr 145: 439-444. (Pubitemid 39345977)
30. Gillum RF, Prineas RJ, Horibe H (1982) Maturation vs age: assessing blood pressure by height. J Natl Med Assoc 74: 43-46. (Pubitemid 12151058)
31. Daniels SR, Kimball TR, Khoury P, Witt S, Morrison JA (1996) Correlates of the hemodynamic determinants of blood pressure. Hypertension 28: 37-41. (Pubitemid 26231087)
32. Jolliffe IT (2002) Principal component analysis. New York: Springer.
33. Woolston A, Tu YK, Baxter PD, Gilthorpe MS (2012) A comparison of different approaches to unravel the latent structure within metabolic syndrome. PLoS One 7: e34410.
34. Reaven GM (1988) Banting lecture 1988. Role of insulin resistance in human disease. Diabetes 37: 1595-1607.
35. Rosen ED, Spiegelman BM (2006) Adipocytes as regulators of energy balance and glucose homeostasis. Nature 444: 847-853. (Pubitemid 46024991)
36. Miller M, Stone NJ, Ballantyne C, Bittner V, Criqui MH, et al. (2011) Triglycerides and cardiovascular disease: a scientific statement from the American Heart Association. Circulation 123: 2292-2333.
37. Kraja AT, Rao DC, Weder AB, Mosley TH, Turner ST, et al. (2005) An evaluation of the metabolic syndrome in a large multi-ethnic study: the Family Blood Pressure Program. Nutr Metab (Lond) 2: 17.
38. Kraja AT, Rao DC, Weder AB, Cooper R, Curb JD, et al. (2005) Two major QTLs and several others relate to factors of metabolic syndrome in the family blood pressure program. Hypertension 46: 751-757. (Pubitemid 43186749)
39. Mercuro G, Deidda M, Piras A, Dessalvi CC, Maffei S, et al. (2010) Gender determinants of cardiovascular risk factors and diseases. J Cardiovasc Med (Hagerstown) 11: 207-220.
40. Pimenta E, Oparil S (2008) Gender and blood pressure. In: Izzo JJ, Black H, Sica D, editors. Hypertension Primer. Philadelphia: Lippincott&Williams.
41. Biaggioni I (2008) Should we target the sympathetic nervous system in the treatment of obesity-associated hypertension? Hypertension 51: 168-171.
42. Alvarez GE, Beske SD, Ballard TP, Davy KP (2002) Sympathetic neural activation in visceral obesity. Circulation 106: 2533-2536. (Pubitemid 35340687)
43. Alvarez GE, Ballard TP, Beske SD, Davy KP (2004) Subcutaneous obesity is not associated with sympathetic neural activation. Am J Physiol Heart Circ Physiol 287: H414-418. (Pubitemid 38802379)
44. Haastrup AT, Stepniakowski KT, Goodfriend TL, Egan BM (1998) Intralipid enhances alpha1-adrenergic receptor mediated pressor sensitivity. Hypertension 32: 693-698. (Pubitemid 28480546)
45. Grekin RJ, Vollmer AP, Sider RS (1995) Pressor effects of portal venous oleate infusion. A proposed mechanism for obesity hypertension. Hypertension 26: 193-198.
46. Zeiher AM, Schachlinger V, Hohnloser SH, Saurbier B, Just H (1994) Coronary atherosclerotic wall thickening and vascular reactivity in humans. Elevated highdensity lipoprotein levels ameliorate abnormal vasoconstriction in early atherosclerosis. Circulation 89: 2525-2532.
47. Lowenstein CJ, Cameron SJ (2010) High-density lipoprotein metabolism and endothelial function. Curr Opin Endocrinol Diabetes Obes 17: 166-170.
48. Kontush A, Chapman MJ (2006) Functionally defective high-density lipoprotein: a new therapeutic target at the crossroads of dyslipidemia, inflammation, and atherosclerosis. Pharmacol Rev 58: 342-374. (Pubitemid 44394906)
49. Soran H, Hama S, Yadav R, Durrington PN (2012) HDL functionality. Curr Opin Lipidol 23: 353-366.
50. Yki-Jarvinen H (2004) Thiazolidinediones. N Engl J Med 351: 1106-1118.
51. Zhang H, Zhang A, Kohan DE, Nelson RD, Gonzalez FJ, et al. (2005) Collecting duct-specific deletion of peroxisome proliferator-activated receptor gamma blocks thiazolidinedione-induced fluid retention. Proc Natl Acad Sci U S A 102: 9406-9411. (Pubitemid 40923576)
52. Guan Y, Hao C, Cha DR, Rao R, Lu W, et al. (2005) Thiazolidinediones expand body fluid volume through PPARgamma stimulation of ENaC-mediated renal salt absorption. Nat Med 11: 861-866. (Pubitemid 41161118)
53. Singh S, Loke YK, Furberg CD (2007) Long-term risk of cardiovascular events with rosiglitazone: a meta-analysis. JAMA 298: 1189-1195. (Pubitemid 47403105)
54. Lipscombe LL (2009) Thiazolidinediones: do harms outweigh benefits? CMAJ 180: 16-17.
55. Evans RM, Barish GD, Wang YX (2004) PPARs and the complex journey to obesity. Nat Med 10: 355-361. (Pubitemid 38508511)
56. Rogol AD, Roemmich JN, Clark PA (2002) Growth at puberty. J Adolesc Health 31: 192-200. (Pubitemid 35434159)
57. Kannel WB, Brand N, Skinner JJ, Jr., Dawber TR, McNamara PM (1967) The relation of adiposity to blood pressure and development of hypertension. The Framingham study. Ann Intern Med 67: 48-59.
58. Freedman DS, Katzmarzyk PT, Dietz WH, Srinivasan SR, Berenson GS (2009) Relation of body mass index and skinfold thicknesses to cardiovascular disease risk factors in children: the Bogalusa Heart Study. Am J Clin Nutr 90: 210-216.